Table 1.
Demographic | n (%) | |
---|---|---|
Sex | ||
Male | 24 (49.0) | |
Female | 25 (51.0) | |
Race | ||
White | 35 (71.4) | |
African American | 11 (22.4) | |
Multiple race | 2 (4.1) | |
Not known | 1 (2.0) | |
Ethnicity | ||
Hispanic | 9 (18.4) | |
Non-Hispanic | 40 (81.6) | |
Delivery type | ||
Vaginal | 14 (28.6) | |
Cesarean section | 35 (71.4) | |
PROM | ||
Yes | 17 (34.7) | |
No | 31 (63.3) | |
Birth | ||
Multiple birth | 21 (42.9) | |
Single birth | 28 (57.1) | |
Resuscitation at birth | ||
Yes | 38 (77.6) | |
No | 11 (22.4) | |
Antibiotics use | ||
Ampicillin | 32 (65.3) | |
Gentamycin | 30 (61.2) | |
Cefotaxime | 3 (6.1) | |
Other* | 1 (2.0) | |
Mean (SD) | Range | |
Gestational age (wks) | 31.0 (1.7) | 26 1/7–33 3/7 |
Birth weight (g) | 1477.4 (417.9) | 703–2640 |
Birth length (cm) | 40.5 (3.2) | 32.5–47.0 |
Birth head circumference (cm) | 28.2 (2.1) | 24.0–34.5 |
SNAPEII | 6.4 (8.9) | 0–44 |
Mother age (y) | 32.5 (5.7) | 19–46 |
Other: ceftazidime and sulfamethoxazole-trimethoprim.
PROM indicates premature rupture of membranes; SNAPEII, Score for Neonatal Acute Physiology–Perinatal Extension II.